secwatch.observer — SEC 8-K summary
======================================

Issuer:     Chemours Co (CC)
CIK:        0001627223
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0000950170-23-055626
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Chemours Q3 2023: Adjusted EPS $0.63; cuts FY Adj. EBITDA guidance to $1.025-1.075B
--------------------------------------------------------------------------------

- Net sales $1.5B (-16% YoY); Net income $20M ($0.13 EPS); Adjusted net income $96M ($0.63 adj. EPS).
- Adjusted EBITDA $247M; FY 2023 guidance lowered ~8% midpoint to $1.025-1.075B.
- Launched TT Transformation Plan targeting ~$100M run-rate cost savings starting 2024.
- Board approved Q3 dividend of $0.25/share; sale of Glycolic Acid business closed for $138M net cash.
- Weakness in TT and APM Advanced Materials driven by macroeconomic environment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1627223/000095017023055626/0000950170-23-055626-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1627223/000095017023055626/cc-20231026.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-055626

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer